Demetria Harris, is a consultant with Murer Consultants, Inc. Mrs. Harris received her Masters’ in Business Systems Information Management and Project Management from Keller Graduate School of Management with Honors. While at Keller, she received a scholarship to complete her Masters of Certificate in HealthCare Administration. Mrs. Harris has a BS in Information Systems Application which she received a partial scholarship from DeVry University to complete her degree.
Since joining Murer, Mrs. Harris has assisted healthcare providers with ongoing audit support for the 340B Drug Pricing Program, which offers significantly reduced pharmaceuticals to safety net hospitals. As a part of her work, Mrs. Harris also assists provider to assure all 340B program operations are fully compliant with all federal regulations and related interpretations for the program. She also ensures that providers optimize their utilization of 340B pricing through full participation in all qualified areas and with all applicable products to insure the highest cost savings throughout the hospital. Mrs. Harris analyzes the efficiency of 340B program policies, procedures, and related approaches, including medications, eligibility, and other cost-monitoring processes to identify and minimize risk.
Mrs. Harris also utilizes her technical expertise to assist with Murer innovation projects, including MACRA, MIPS, the EHR Incentive Program, PQRS, bundled payments, clinical integration, and more. In addition to providing regulatory guidance for these programs, Mrs. Harris also guides clients through the technical aspects of program development and produces cost/benefit analyses relative to their implementation.
Prior to joining Murer, Mrs. Harris worked as a 340B Program Manager compiling the daily activities for designated clinical functions to ensure that the business and clinical goals and objectives were achieved. In her role, she also managed and coordinated the 340B drug pricing program for all covered locations, child sites, and contract pharmacies. Mrs. Harris developed and implemented updated policies and procedures for the 340B drug pricing program. In doing so, she ensured compliance with HRSA regulations and other federal and state rules related to the 340B drug pricing program while also monitoring the system-wide outpatient services to identify qualified areas where the 340B drug pricing program could be expanded.
In addition, Mrs. Harris worked as a Program Delivery Manager for a leading insurance company delivering a unique business solution that helped save the organization $325 million by implementing a new software program.